Intra-Articular Syringe Hyalotend 20mg/2ml 1 Piece Fidia
16% off
€37,61
€45,00
Unit price
/
Unavailable
Tax included, shipping and discounts calculated at checkout.
FIDIA FARMACEUTICI | SKU:
980185728
Intra-Articular Syringe Hyalotend 20mg/2ml 1 Piece Fidia is backordered and will ship as soon as it is back in stock.
Shipping Costs and Times
Shipping Costs and Times
- Order fulfillment within 24 hours and delivery within the following 48/72 hours.
- Shipping cost: always free for orders over €49.90, otherwise it costs €4.99.
Payments
Payments
Payment information is processed securely. We do not store credit card information or have access to your credit card information.
Returns and Refunds
Returns and Refunds
You can return and receive a refund for the item within 30 days. See full policy here.

Do you need help?
Our customer service is here to help you!
- Contact us by phone, email or WhatsApp, from Monday to Friday, from 9:00 to 20:00 .
- For common questions, such as tracking your order or checking its fulfillment status, you can count on our artificial intelligence , available 24/7 .
We are always at your side to offer you fast and effective support!
Description
Description
INTRA-ARTICULAR SYRINGE HYALOTEND 20MG/2ML 1 PIECE FIDIA
PHIDIAS
HYALOTEND
Description
Pre-filled syringe with hyaluronic acid sodium salt solution for peritendinous use. Hyalotend consists of a viscous solution of hyaluronic acid sodium salt (500-730 kDa) obtained by bacterial fermentation, in buffered physiological solution, for peritendinous injection. The solution (20 mg/2 ml) is contained in a pre-filled syringe and is supplied sterile. Hyaluronic acid is one of the main components of synovial fluid, is produced in the normal tendon sheath and is a main component of the extracellular matrix of the tendon. The administration of exogenous hyaluronic acid sodium salt into the peritendinous space, thanks to its viscoelastic properties, allows to reduce the surface friction of the tendons, increases the sliding capacity, reduces pain and improves tendon function in tendinopathy, thus accelerating the return to normal activities and sports. Hyalotend is indicated for the treatment of pain and improvement of tendon elasticity in tendinopathy of the upper and lower limbs.
Composition
Hyaluronic acid sodium salt, sodium chloride, sodium phosphate dibasic dodecahydrate, sodium phosphate monobasic dihydrate, water for injections.
How to use
The product should be administered only by experienced medical personnel. Use an ultrasound probe to guide the injection if necessary. All rules regarding aseptic administration technique must be strictly followed. Do not use in conjunction with disinfectants containing quaternary ammonium salts, as hyaluronic acid may precipitate in their presence. Use a suitable sterile needle (21-25 G) according to medical advice. Discard the syringe and needle after single use.
Administer 3 peritendin injections of the product at weekly intervals, according to medical advice. If necessary, multiple tendons can be treated simultaneously. Each syringe is intended for the injection of a single tendon. Repeated treatments can be performed if required.
Warnings
Hyalotend should not be administered to patients with known hypersensitivity to any component of the product. Hyalotend peritend injections are contraindicated in case of infections or skin diseases in the area of the injection site. Hyalotend has not been tested on pregnant women or individuals under 18 years of age and is therefore contraindicated in these patient populations. Do not use the product after the expiry date printed on the package. Do not use the product if the package is opened or damaged: the sterility of the solution is guaranteed as long as the package is closed and intact. The syringe is for single use, which means that it should be used for a single injection only. The assembled syringe should be discarded immediately after use, regardless of whether the solution has been completely administered or not. If a syringe is used for a subsequent injection, there is a risk of contamination which could lead to illness, infection and/or serious harm to the patient. If the product is reworked and/or reused, Fidia Farmaceutici cannot guarantee its performance, functionality, material structure, cleanliness or sterility. Rework and/or reuse may cause serious damage to the health and safety of the patient. After use, dispose of in accordance with current regulations. As with any invasive joint procedure, it is recommended to be careful not to overload the joint immediately after the peritendinous injection. Keep out of the reach of children. Local reactions such as pain and heat or redness/swelling/bruising at the injection site may occur. These symptoms are usually transitory and disappear spontaneously within a few days by resting the affected joint and applying ice locally. Local or systemic allergic reactions due to individual hypersensitivity have been sporadically recorded after the injection of hyaluronic acid.
Conservation
The product should be stored at a temperature not exceeding 25 °C in the original packaging protected from light. Do not freeze.
Format
Carton containing 1 pre-filled syringe sealed in a blister.
Carton containing 3 pre-filled syringes, each sealed in a blister.
The 20 mg/2 ml solution of hyaluronic acid sodium salt contained in the pre-filled syringe is sterilized with steam.
Cod. 10000122, 10000123
Pre-filled syringe with hyaluronic acid sodium salt solution for peritendinous use. Hyalotend consists of a viscous solution of hyaluronic acid sodium salt (500-730 kDa) obtained by bacterial fermentation, in buffered physiological solution, for peritendinous injection. The solution (20 mg/2 ml) is contained in a pre-filled syringe and is supplied sterile. Hyaluronic acid is one of the main components of synovial fluid, is produced in the normal tendon sheath and is a main component of the extracellular matrix of the tendon. The administration of exogenous hyaluronic acid sodium salt into the peritendinous space, thanks to its viscoelastic properties, allows to reduce the surface friction of the tendons, increases the sliding capacity, reduces pain and improves tendon function in tendinopathy, thus accelerating the return to normal activities and sports. Hyalotend is indicated for the treatment of pain and improvement of tendon elasticity in tendinopathy of the upper and lower limbs.
Composition
Hyaluronic acid sodium salt, sodium chloride, sodium phosphate dibasic dodecahydrate, sodium phosphate monobasic dihydrate, water for injections.
How to use
The product should be administered only by experienced medical personnel. Use an ultrasound probe to guide the injection if necessary. All rules regarding aseptic administration technique must be strictly followed. Do not use in conjunction with disinfectants containing quaternary ammonium salts, as hyaluronic acid may precipitate in their presence. Use a suitable sterile needle (21-25 G) according to medical advice. Discard the syringe and needle after single use.
Administer 3 peritendin injections of the product at weekly intervals, according to medical advice. If necessary, multiple tendons can be treated simultaneously. Each syringe is intended for the injection of a single tendon. Repeated treatments can be performed if required.
Warnings
Hyalotend should not be administered to patients with known hypersensitivity to any component of the product. Hyalotend peritend injections are contraindicated in case of infections or skin diseases in the area of the injection site. Hyalotend has not been tested on pregnant women or individuals under 18 years of age and is therefore contraindicated in these patient populations. Do not use the product after the expiry date printed on the package. Do not use the product if the package is opened or damaged: the sterility of the solution is guaranteed as long as the package is closed and intact. The syringe is for single use, which means that it should be used for a single injection only. The assembled syringe should be discarded immediately after use, regardless of whether the solution has been completely administered or not. If a syringe is used for a subsequent injection, there is a risk of contamination which could lead to illness, infection and/or serious harm to the patient. If the product is reworked and/or reused, Fidia Farmaceutici cannot guarantee its performance, functionality, material structure, cleanliness or sterility. Rework and/or reuse may cause serious damage to the health and safety of the patient. After use, dispose of in accordance with current regulations. As with any invasive joint procedure, it is recommended to be careful not to overload the joint immediately after the peritendinous injection. Keep out of the reach of children. Local reactions such as pain and heat or redness/swelling/bruising at the injection site may occur. These symptoms are usually transitory and disappear spontaneously within a few days by resting the affected joint and applying ice locally. Local or systemic allergic reactions due to individual hypersensitivity have been sporadically recorded after the injection of hyaluronic acid.
Conservation
The product should be stored at a temperature not exceeding 25 °C in the original packaging protected from light. Do not freeze.
Format
Carton containing 1 pre-filled syringe sealed in a blister.
Carton containing 3 pre-filled syringes, each sealed in a blister.
The 20 mg/2 ml solution of hyaluronic acid sodium salt contained in the pre-filled syringe is sterilized with steam.
Cod. 10000122, 10000123